Company Filing History:
Years Active: 1999-2001
Title: Innovations of John David Firth
Introduction
John David Firth is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid constructs. With a total of 2 patents, Firth's work has implications for gene therapy and prodrug activation systems.
Latest Patents
Firth's latest patents include methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements. These constructs are designed to be in operable linkage with a coding sequence of a gene of interest. Specifically, the patents disclose nucleic acid constructs that comprise genes encoding prodrug activation systems or cytokines, which are crucial for advancing therapeutic applications.
Career Highlights
Firth is currently associated with Oxford Biomedica (UK) Limited, where he continues to innovate in the field of gene therapy. His work focuses on developing advanced methods for gene expression that can enhance the efficacy of treatments.
Collaborations
Firth has collaborated with prominent figures in the field, including Peter John Ratcliffe and Adrian Llewellyn Harris. These collaborations have further enriched his research and contributed to the advancement of biotechnology.
Conclusion
John David Firth's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative solutions in gene therapy and related areas.